Bioheart, Inc. To Introduce At-Home Heart Failure Monitor For Congestive Heart Failure Patients

The company who will manufacture, RTX also has a number of consumer products for use with services such as Skype, so this appears to be combining the joint efforts of BioHeart, who’s technology involves stem cell therapy and now a device than can monitor the progress. The website has collective pages of information regarding their clinical trials. The device will collect information and send it to a clinician to add to the data base and is wireless. The hope is to be on top of issues to cut down on the amount of ER visits for patients and hospital stays, and of course, cost. BD

The Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home intelligent device designed specifically to improve available healthcare to patients outside hospitals who are suffering from heart failure. The device, manufactured by RTX Healthcare A/S (Denmark), has 510k market clearance from the US Food and Drug Administration for marketing in the U.S. and CE mark approval for marketing in Europe and other countries that follow this mark. The Company is planning to begin immediate commercial distribution.